News

Worms and other parasites cause numerous and widespread tropical diseases which are largely overlooked. At the DZIF, research teams are focused on fighting these diseases. Since August 2020

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as

Patients have a high risk of serious infections after organ or stem cell transplantation. The number of these complications is large, but too little is currently known about the links between

Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi

The further development of the vector vaccine MVA-SARS-2-S against COVID-19 by IDT Biologika GmbH and the German Center for Infection Research (DZIF) is postponed. The vector vaccine has been

The search for effective antiviral agents against the new coronavirus is in full swing. Using a novel approach, Tübingen bioinformaticians have now discovered a weakness in the virus that could be

Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer

Hepcludex (bulevirtide) is the first medication for the treatment of hepatitis D, a virus blocker whose development had been masterminded by DZIF Professor Dr Stephan Urban of Heidelberg University

Professor Rolf Müller, Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has been awarded the Gottfried Wilhelm Leibniz Prize by the German Research Foundation

Scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) identified a multidrug resistant Tuberculosis-strain in Southern Africa, that is not detected by modern